Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

Trial Details

NCT ID

NCT06646627

Phase

PHASE1

Sponsor

Stanford University

Status

RECRUITING

Cancer Type

Ovarian Cancer

Interventions

• B7-H3CART

Locations (sample)

• Palo Alto, California, United States|37.44188,-122.14302

Key Eligibility Criteria

• Disease: Histologically or cytologically confirmed diagnosis of ovarian cancer including serous, endometrioid, clear cell, mucinous, mixed epitheli…
• Have measurable disease. Measurable disease is defined as at least 1 lesion that can be accurately measured in at least 1 dimension (longest diamet…
• B7-H3 positive expression on malignant cells is NOT required but archival tissue must be available, or the subject must be willing to undergo tissu…
• Age: ≥ 18 years of age

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.